These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6240405)

  • 21. Effect of bepridil in patients with chronic stable angina: results of a multicenter trial.
    Hill JA; O'Brien JT; Alpert JS; Gore JM; Zusman RM; Christensen D; Boucher CA; Vetrovec G; Borer JS; Friedman C
    Circulation; 1985 Jan; 71(1):98-103. PubMed ID: 3880521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of isradipine, alone and in combination, in the treatment of angina pectoris.
    Rüegg PC; Nelson DJ
    Am J Med; 1989 Apr; 86(4A):70-4. PubMed ID: 2565689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients.
    Lopez LM; Rubin MR; Holland JP; Mehta JL
    Am Heart J; 1985 Nov; 110(5):991-6. PubMed ID: 3933316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
    Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].
    Blazek G; Heeger H; Kubicek F
    Dtsch Med Wochenschr; 1977 Jan; 102(3):81-4. PubMed ID: 832584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiischemic and hemodynamic effects of intravenous isradipine, a new calcium antagonist, in coronary heart disease: a comparative double-blind cross-over study with nifedipine.
    Burger W; Herholz H; Burger K; Kober G
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):764-8. PubMed ID: 1703598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group.
    Braun S; van der Wall EE; Emanuelsson H; Kobrin I
    J Am Coll Cardiol; 1996 Feb; 27(2):317-22. PubMed ID: 8557900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Fantofarone Study Group.
    Glasser SP; Singh SN; Humen DP
    J Clin Pharmacol; 1997 Jan; 37(1):53-7. PubMed ID: 9048273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isradipine therapy in chronic stable angina pectoris--comparison with nifedipine.
    Currie P; Saltissi S
    Eur Heart J; 1991 Jul; 12(7):807-12. PubMed ID: 1832382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist.
    Burger W; Neidel S; Kober G
    Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
    Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F
    Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
    Shapiro W; DiBianco R; Thadani U
    Am J Cardiol; 1985 Mar; 55(7):36C-42C. PubMed ID: 3919556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris.
    O'Hara MJ; Khurmi NS; Bowles MJ; Raftery EB
    Eur Heart J; 1985 Aug; 6(8):689-94. PubMed ID: 4054138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Chen YH; Liu RC; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
    Detry JM; De Coster PM; Renkin J
    Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.